Tradestie Institutional Equity Comparison Engine

RAPT vs VRDN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VRDN Overall Edge

VRDN Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Viridian Therapeutics, Inc. Common Stock (VRDN) driven by superior Valuation, Growth & Margin, Options & Structure while RAPT counters with relative strength in Momentum & Technical. Fundamentally, RAPT trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VRDN at 1.0x Forward P/E and -1781.4% operating margin (-63.5% YoY). In options structure, RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against VRDN sits in SURGE (20th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VRDN
RAPT N/M vs VRDN 1.0x Fwd P/E
Growth & Margin Winner VRDN
Op Margin 0.0% vs -1781.4% ยท YoY -100.0% vs -63.5%
Momentum & Technical Winner RAPT
1Y +480.2% vs +6.6% ยท 52W Pos 100% vs 81%
Options & Structure Winner VRDN
UNCLASSIFIED (<1st %ile IV) vs SURGE (20th %ile IV)
RAPT NASDAQ
RAPT Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$58.02
+0.07% 1D
Market Cap $1.7B
1M Return +0.68%
1Y Return +480.2%
Forward P/E N/M
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 61.0 Mom 40.0
VRDN NASDAQ
Viridian Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$30.36
-1.64% 1D
Market Cap $3.5B
1M Return +59.56%
1Y Return +6.58%
Forward P/E 1.0x
Unified AI Score
36.8 / 100 SELL
Tech 50.0 Fund 32.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RAPT +480.2% VRDN +6.58% Spread: +96.81 pp (RAPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RAPT TTM Op. Margin: 0.0% VRDN TTM Op. Margin: -1781.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAPT vs VRDN. Trailing 12-month operating profitability (RAPT 0.0% vs VRDN -1781.4%) and valuation multiples (RAPT N/M vs VRDN 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RAPT (4) vs VRDN (5)
Institutional Metric RAPT VRDN Criterion Row Winner
Market Capitalization Scale $1.7B $3.5B Larger Scale VRDN
Trailing P/E Ratio Valuation N/M 1.0x Lower Multiple VRDN
Forward P/E Ratio Valuation N/M 1.0x Lower Multiple VRDN
Revenue Growth (YoY) Growth -100.0% -63.5% Higher Growth VRDN
Operating Margin (TTM) Profitability 0.0% -1781.4% Higher Margin RAPT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -85.4% -83.7% Higher ROE VRDN
52-Week Range Position Momentum 100% ($1โ€“$58) 81% ($13โ€“$34) Stronger Trend RAPT
Beta / 30D Volatility Risk Regime -0.02ฮฒ ยท 2% Vol 1.13ฮฒ ยท 65% Vol Lower Realized Risk RAPT
Unified Institutional Score Composite Signal 52.4 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite RAPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RAPT vs VRDN Buy Guide
RAPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RAPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VRDN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live VRDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RAPT nor VRDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.